Lines drawn on comparing medical treatments
The Obama administration plans to spend $1.1 billion over the next few years on studies to compare the effectiveness of competing treatments for common conditions like back pain, heart disease, and prostate cancer. The studies will be publicly released, to help doctors and patients decide which treatment options they want to pursue. Supporters include many medical researchers, consumer groups, unions, and insurers. But potential opponents warn that the comparative effectiveness movement could lead to inadequate treatment for some patients and even the rationing of healthcare.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Hospitals Likely to Outsource ICD-10 at Launch
- IOM Identifies GME Problems, Calls for Finance Changes
- CMS Confirms ICD-10 Deadline
- Anatomy of 3 Health System Rebranding Efforts
- Premium Subsidy Fight Creating Uncertainty for Hospitals, Health Plans
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts